K. Lehtomäki

发表

Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study

J. Kononen, T. Kuopio, A. Ristimäki, 2022, British Journal of Cancer.

Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer

C. Haglund, H. Joensuu, P. Kellokumpu-Lehtinen, 2021, Cancers.

Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study

J. Kononen, E. Lantto, H. Isoniemi, 2021, The Lancet regional health. Europe.

Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study

J. Kononen, H. Sintonen, H. Isoniemi, 2022, Cancers.

Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)

J. Kononen, H. Isoniemi, B. Glimelius, 2023, Journal of clinical medicine.

Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer

C. Haglund, H. Joensuu, P. Kellokumpu-Lehtinen, 2023, International journal of molecular sciences.

Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study

J. Kononen, T. Kuopio, A. Ristimäki, 2022, The British journal of surgery.

Association between Computed Tomography-Determined Loss of Muscle Mass and Impaired Three-Month Survival in Frail Older Adults with Cancer

M. Bärlund, H. Huhtala, O. Arponen, 2023, Cancers.

Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)

J. Sundström, T. Salminen, R. Ristamäki, 2024, Cancers.

Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial)

N. Lundbom, R. Blanco Sequeiros, A. Ristimäki, 2021, ESMO open.